| Mrs Dorota Kus, PHARMD | |
|
570 Shelburne Rd, Burlington, VT 05401-5049 | |
| (802) 860-3311 | |
| (802) 860-2980 |
| Full Name | Mrs Dorota Kus |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 570 Shelburne Rd, Burlington, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134588874 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 033.0095973 (Vermont) | Primary |
| 183500000X | Pharmacist | 051298460 (Illinois) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Dorota Kus, PHARMD 570 Shelburne Rd, Burlington, VT 05401-5049 Ph: (802) 860-3311 | Mrs Dorota Kus, PHARMD 570 Shelburne Rd, Burlington, VT 05401-5049 Ph: (802) 860-3311 |
News Archive
Kaiser Health News staff writer Christopher Weaver details events similar to this summer's "death panel" controversy, but that happened decades ago. "It was early summer. A senior federal health official wrote a memo suggesting that living wills - documents that can convey patients' wishes about when to end life support - could help curb health-care costs.
Grown-ups aren't the only ones making exciting scientific discoveries these days. Two middle school students from Wisconsin joined a team of scientists who are reporting the first glimpse of the innermost structure of a key bacterial enzyme. It helps activate certain antibiotics and anti-cancer agents so that those substances do their job. Their study appears in ACS' weekly journal Biochemistry.
Artisanal (non-pharmaceutical) cannabidiol (CBD) products have become popular in recent years for their apparent therapeutic effects. CBD — a naturally occurring compound of the cannabis plant legally derived from hemp — is used widely as a naturopathic remedy for a number of health conditions, including epilepsy and seizure disorders.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reported positive, statistically significant top-line results from the MARINE study, its first Phase 3 clinical trial of lead drug candidate AMR101.
› Verified 4 days ago
Daeun Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 514 Farrell St, Burlington, VT 05401 Phone: 802-651-0597 | |
Dr. Kyle Maxwell, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 158 Cherry St, Burlington, VT 05401 Phone: 802-862-1562 | |
Lea Juzek, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 570 Shelburne Rd, Burlington, VT 05401 Phone: 802-860-3311 Fax: 802-860-2980 | |
Alan Mccampbell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1127 North Ave Ste 11, Burlington, VT 05408 Phone: 802-862-7752 | |
Hae Ji Yoon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 308 Shelburne Rd, Burlington, VT 05401 Phone: 802-864-8154 | |
Dr. Sarah Abdalla, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 35 Church St, Burlington, VT 05401 Phone: 803-651-1018 | |
Debra M Gibbs, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 S Prospect St, Suite 1413, Burlington, VT 05401 Phone: 802-847-5519 Fax: 802-847-1076 |